Fecal occult blood tests. A cost-effectiveness analysis

Int J Technol Assess Health Care. Spring 1998;14(2):290-301. doi: 10.1017/s0266462300012265.

Abstract

A range of fecal occult blood tests are presently on the market and could potentially be used in population screening programs for the detection of colorectal neoplasms. This paper estimates the relative cost-effectiveness of alternative tests and concludes that the unhydrated Hemoccult II is the most cost-effective. However, the incremental costs per life-year of the HemeSelect test and the rehydrated Hemoccult II test are in line with incremental costs observed in breast cancer and cervical cancer programs.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Colorectal Neoplasms / prevention & control*
  • Cost-Benefit Analysis
  • Diagnostic Tests, Routine / economics*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Occult Blood*
  • Reagent Kits, Diagnostic / economics*
  • Sensitivity and Specificity
  • Technology Assessment, Biomedical

Substances

  • Reagent Kits, Diagnostic